BioTrove (BTRV) Files $75M IPO
BioTrove Inc. (Nasdaq: BTRV) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $75 million. The company plans to list on the NASDAQ under the stock symbol "BTRV".
The offering is being made through Piper Jaffray, Lazard Capital Markets and Robert W. Baird.
BioTrove develops, manufactures and markets innovative instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics. Its two marketed systems, OpenArray and RapidFire, accelerate research, development and commercial progress across multiple fields, from drug discovery to agricultural science, and from food and water supply safety to molecular diagnostics. [BCS]
Stocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
